Jukka Lyytinen

A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology

Petra Pasanen, Liisa Myllykangas, Maija Siitonen et al. · Neurobiology of Aging · 2014 · 512 citations

Neurodegenerative Diseases, Medicine, Genetics +5

Persistent organochlorine pesticides in serum and risk of Parkinson disease

Marc G. Weisskopf, Paul Knekt, Éilis J. O’Reilly et al. · Neurology · 2010 · 159 citations · Full text

Reduced risk of Parkinson’s disease associated with lower body mass index and heavy leisure-time physical activity

Katri Sääksjärvi, Paul Knekt, Satu Männistö et al. · European Journal of Epidemiology · 2014 · 87 citations

Physical Activity, Physical Activity Epidemiology, Body Composition +9

Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily

Mikko Kuoppamäki, Kirsi Korpela, Reijo J. Marttila et al. · European Journal of Clinical Pharmacology · 2009 · 80 citations · Full text

Wernicke's encephalopathy: is diffusion-weighted MRI useful?

Juha Halavaara, Antti Brander, Jukka Lyytinen et al. · Neuroradiology · 2003 · 73 citations

Diffusion-weighted Mri Useful, Medical Imaging, Neuroimaging +7